Yeonjae Kate L.

YeonJae Kate L. has a diverse work experience spanning multiple industries and roles. YeonJae Kate started their career in 2003 as a Product Specialist at National Beef Packing Company LLC before moving on to become a Product Manager at LG Life Sciences and Novartis. In 2009, they joined Daewoong Pharmaceuticals as Deputy General Manager and then transitioned to Bausch + Lomb as the Head of Marketing for Pharmaceutical Marketing. In 2014, they became the Director of Commercial Excellence and Business Development at UCB, where they later served as the Country Head and Head of Neurology. YeonJae Kate also held the position of Head of Neurology Korea and Head of Hemophilia Business Unit Pacific Rim at UCB. YeonJae then moved to Sanofi as the Head of Rare Blood Disorders before joining EUSA Pharma as the APAC General Manager. YeonJae Kate also worked at GLG as a Global Counsel. Currently, they are the Head of Asia at Recordati Rare Diseases Inc.

YeonJae Kate L.'s education history begins with their attendance at Seattle Pacific University from 1994 to 1998. During this time, they pursued a pre-med program in Biology. YeonJae Kate then went on to enroll at Yonsei University from 1998 to 2002, where they obtained a Bachelor of Science (BS) degree in Biology. It is also mentioned that YeonJae Kate L. earned a Bachelor of Applied Science (BASc) degree in Biology from Yonsei University, although the specific years of study are not provided.